Clinical Trial Update: Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enzastaurin versus placebo for brain metastases from lung cancer after whole-brain radiation therapy has completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer, Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-05